Clinical Trials Logo

Hallucinations, Verbal Auditory clinical trials

View clinical trials related to Hallucinations, Verbal Auditory.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06013748 Recruiting - Clinical trials for Hallucinations, Verbal Auditory

Virtual Reality Therapy for Voice Hearing (VR-VOICES): a Randomized Controlled Trial

VR-VOICES
Start date: October 31, 2022
Phase: N/A
Study type: Interventional

Rationale: Auditory verbal hallucinations (AVH) - hearing voices that others cannot hear - are common in mental illnesses. For many people AVH are distressing, disabling and persistent, despite medication. Current psychological interventions show low to medium effects. Preliminary studies suggest that an innovative empowering psychological therapy using computer simulations representing the AVH (avatars) can be effective for reducing AVH distress and frequency. Virtual reality (VR) has the potential to improve this treatment. Therefore, we developed a novel VR treatment for this problem. In this study, the effect of this treatment will be investigated. Objective: To test the effect of a novel VR treatment for AVH (VR-VOICES) on distress and frequency of AVH in patients with a psychiatric disorder. Furthermore, to investigate the effect of VR-VOICES on clinical symptoms, quality of life, and healthcare costs of the treatment.

NCT ID: NCT03762746 Recruiting - Clinical trials for Hallucinations, Verbal Auditory

Transcranial Magnetic Stimulation (TMS) for Patients With Treatment Resistant Auditory Verbal Hallucination

TMS
Start date: February 1, 2018
Phase: Phase 3
Study type: Interventional

This study will evaluate the effect of repetitive transcranial magnetic stimulation (rTMS) in schizophrenia with treatment resistant auditory verbal hallucination